AFC-HD AMS Life Science Co., Ltd.
Notice of Completion of Exercise and Monthly Status of the First Callable Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued to Third Parties through the Consolidated Subsidiary Sakaeya Co., Ltd.
Today, consolidated subsidiary Saikaya announced completion of the first exercise of stock acquisition rights through third-party allotment. The number of issued shares is 8,439,350, capital stock is 936,088,430 yen, and no remaining rights as of exercise completion. With a monthly exercise total of 9,860 shares, full exercise eliminates the dilution concern. Going forward, capital policy will transition to growth-stage, promoting strengthening of the business base and improvement of capital efficiency.
Key Figures
- Issued shares: 8,439,350 shares
- Capital stock: 936,088,430 yen
- Total number of stock acquisition rights: 9,860 units
AI要約
Section Heading
Following Saikaya's full exercise of its first stock acquisition rights, we announce the completion of capital policy. This eliminates future stock dilution risk and advances efforts to meet the listing maintenance standards. Going forward, funds raised will be used to strengthen the business base, with initiatives including realization of the latent value of real estate to improve earnings power and capital efficiency.
Section Heading 2
With the completion of the capital policy, we will focus on mid-to-long term corporate value enhancement. We will emphasize dialogue with shareholders and investors, and continuously promote meeting the listing maintenance standards and improving market liquidity. Going forward, we will implement measures including realization of latent value of held real estate, strengthen the business base, and improve capital efficiency to pursue growth.
AFC-HD Amus Life Sciences
Company overview · Stock price · Financial data · All IR
